Multiple sclerosis: open trials in Slovenia

• NCT07827586

  Non-interventional Study of Subcutaneous Ocrelizumab in Persons With Relapsing-Remitting Multiple Sclerosis

  Research · Hoffmann-La Roche

  University Medical Centre, Ljubljana

  Registry updated 2026-10-30

• NCT07299019

  A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

  Trial Treatment · Phase 3 · Zenas BioPharma (USA), LLC

  University Medical Center Ljubljana, Ljubljana

  Registry updated 2026-10-27

• 2024-512914-16-00

  A Randomized, Double-blind, Study to Demonstrate Pharmacokinetic Similarity, and Evaluate Safety, Immunogenicity, Pharmacodynamics and Clinical Effects between ABP 692 and Ocrevus® (Ocrelizumab) in Subjects with Relapsing-remitting Multiple Sclerosis

  Trial Treatment · Phase 3 · Amgen Inc.

  University Medical Center Ljubljana, Ljubljana · Univerzitetni klinični center Maribor, Maribor

  Registry updated 2026-10-20

• NCT07225504

  A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

  Trial Treatment · Phase 3 · Novartis Pharmaceuticals

  Novartis Investigative Site, Ljubljana

  Registry updated 2026-10-13

• 2025-521546-23-00

  A clinical trial to find out how well LOU064 (remibrutinib) works and how safe it is for people with secondary progressive multiple sclerosis

  Trial Treatment · Phase 3 · Novartis Pharma AG

  Splosna Bolnisnica Celje, Celje · University Medical Center Ljubljana, Ljubljana · Univerzitetni klinični center Maribor, Maribor

  Registry updated 2026-07-30

All Multiple sclerosis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error